Biggest News Aggregation in the World
📰 Leukemia News

Page 209 - Leukemia News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.

Cambodian missionary fighting leukemia waited more than a week for emergency delivery from AmeriGas

Cambodian missionary fighting leukemia waited more than a week for emergency delivery from AmeriGas and last updated 2021-02-24 22:29:16-05 SUNFIELD, Mich. — An Ionia County man battling cancer had some big issues with AmeriGas. He tells FOX 17 the company ignored his pleas for propane after he ran out. That’s when a local non-profit got involved to try and fix the situation. About a month ago, Heap Him and his family went more than a week with no heat or means to cook. When the gas f...
Tina Conner Wellman Ionia Community Awareness Heap Him Sparrow Ionia Hospital Diane Grummet Cancer Patient

Sarasota girl fighting leukemia gets to experience dream career as U.S. Air Force pilot

Sarasota girl fighting leukemia gets to experience dream career as U.S. Air Force pilot 5-year-old girl with cancer gets taste of dream career and last updated 2021-02-23 21:11:46-05 TAMPA, Fla. — Five-year-old Ever Young loves planes and wants to be an air force pilot when she grows up just like her great grandfather. "The first time she was on an airplane, she goes, I wanna fly this thing and I said one day baby you’ll do it," said Jimmy Young Jr., Ever’s father. But what start...
Jimmy Young Jr Macdill Air Five Year Old Ever Young Macdill Air Force National Pediatric Cancer Foundation Fashion Funds

Syngene brings out novel approach to treat acute myeloid leukaemia

Syngene brings out novel approach to treat acute myeloid leukaemia Syngene brings out novel approach to treat acute myeloid leukaemia 24 February 2021 | News The article details important findings and solutions that were brought forth by the scientists in the novel approach for the treatment of Acute Myeloid Leukaemia (AML) Source credit: Shutterstock Two Syngene scientists, Vijaykumar Chennupati and Balaji Ramachandran, co-authored an article titled ‘Selective recruitment of γδ T ...
Balaji Ramachandran Vijaykumar Chennupati Nature Publishing Group Two Syngene Nature Publishing Acute Myeloid Leukaemia

Researchers Halt Trial of Promising Sickle Cell Treatment

Researchers Halt Trials of Promising Sickle Cell Treatment Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible. Researchers working in the cellular and molecular therapeutics branch at the National Heart, Lung and Blood Institute in Bethesda, Md.Credit...Erin Scott/Reuters Feb. 22, 2021 Just when it seemed that a new gene therapy for sickle cell disease was sailing toward success, the company developing the treatment f...
United States San Antonio University Of Texas Davida Williams Johnf Tisdale Melissaj Frei Jones

Relapsed Chronic Lymphocytic Leukemia Market Research Report Insights

market in 7MM is expected to change in the study period 2017-2030.   Relapsed Chronic Lymphocytic Leukemia   market trends of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criterias, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and vie...
New York United States United Kingdom Priya Maurya Company Name Chronic Lymphocytic Leukemia
Source: menafn.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Study reveals new drug therapy for leukemia patients

Study reveals new drug therapy for leukemia patients ANI | Updated: Feb 20, 2021 23:11 IST Washington [US], February 20 (ANI): A clinical study by the scientists of McMaster University claims to have taken an early step towards drug therapy for acute myeloid leukemiapatients. During the research published in the Cell Reports Medicine journal, the team discovered that for acute myeloid leukemia (AML) patients, there is a dopamine receptor pathway that become...
United States Mick Bhatia Canadian Cancer Society Mcmaster University Canada Research Cell Reports Medicine
Source: aninews.in

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities Researchers from Rutgers Cancer Institute of New Jersey, the states only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health faci...
Andrewm Evens Emily Henderson Lymphoma Program At Rutgers Cancer Institute Rutgers Robert Wood Johnson Medical School Robert Wood Johnson University Hospital Rutgers Cancer Institute Of New Jersey

Researchers evaluate frequency of SARS-CoV-2 in hematology/oncology settings

Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.
Andrewm Evens Emily Henderson Lymphoma Program At Rutgers Cancer Institute Rutgers Robert Wood Johnson Medical School Robert Wood Johnson University Hospital Rutgers Cancer Institute Of New Jersey

A new method for controlling leukemic stem cells

A new method for controlling leukemic stem cells Leukemia is caused by leukemic stem cells which are resistant to most known therapies. Relapses are also due to this resistance. Leukemic stem cells arise from normal blood-forming (hematopoietic) stem cells. Because they are closely related, leukemic and hematopoietic stem cells share many of the same signaling pathways. If the proliferation of leukemic stem cells is to be stopped, it is crucial to find signaling pathways that are active only in...
Adrian Ochsenbein Emily Henderson Department Of Medical Oncology At Inselspital Nature Communications Bern University Hospital Medical Oncology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science